Heatwave and Mental Health (Credit-Freepik)
The heat waves are rising all over the world and causing a lot of damage. While there are issues of dehydration and heat strokes, studies are suggesting that it might also be responsible for declining mental health, the heat among other things is not only affecting the physicality of human beings but is also having adverse mental health.
Emotional distress: The heat can trigger mood swings, making you feel irritable, anxious, depressed, or even aggressive. You may not be able to predict your reaction, you may be good one moment and then any minor inconvenience will make you angry or sad. Heat often triggers that helplessness in people.
Scattered Focus: Concentrating on tasks becomes a struggle when it's hot. Simple things feel overwhelming, and staying focused is a challenge. While you may be in the zone working on completing something, the heat and sweating will disrupt your flow and then you will not be able to focus on anything other than the heat.
Sleepless Nights: High temperatures, especially at night, disrupt your sleep. This lack of rest can leave you feeling tired, and grumpy, and worsen existing mental health issues. All humans require a comfortable temperature to sleep in, if your body is too wound up or heated up, it will not be able to relax and sleep.
Feeling the Pressure: The heat can pile on stress and make you feel overwhelmed. Concerns about the heat itself or its impact on other aspects of your life can contribute to this feeling. You will feel overwhelmed and unable to work on anything else. The heat makes you feel a certain helplessness, as you cannot stop the sun or turn down the heat.
Body Blues: The heat can cause physical symptoms that affect your mental well-being. Headaches, fatigue, dizziness, and nausea can all contribute to anxiety and low mood. When your body is already fatigued, the urge to do anything else disappears. Your body is drained of energy to function at all and will seek rest and sleep.
Behavioural Shifts: The heat can influence your behaviour. You might act impulsively or have difficulty managing anger. It's like the heat turns up your emotional thermostat. When your body and brain are overheating, it is difficult to think straight and you will grasp at straws to release this energy and pressure off of you.
Some other side effects of the heat are.
Credits: Canva
Gabapentin was first approved decades ago for epilepsy and nerve pain linked to shingles. Over time, it has turned into one of the most frequently prescribed medicines in the United States. In 2024 alone, around 15.5 million people were given prescriptions for it, placing it seventh among the country’s most prescribed drugs. Its popularity grew around a reassuring belief that it could ease pain without carrying the addiction risks long associated with opioids.
For a growing number of patients, that expectation has fallen short, according to reporting by The Wall Street Journal
Gabapentin is a prescription drug that belongs to a group of medicines known as anticonvulsants, also called anti-epileptic drugs. It is mainly prescribed to manage specific seizure disorders and to treat nerve-related pain. The medication is sold under brand names such as Neurontin, Gralise, and Horizant and comes in several forms, including capsules, tablets, extended-release tablets, and a liquid taken by mouth.
John Avery, a former high school physical education teacher from Illinois, was given gabapentin after a slipped disc triggered nerve pain. He recalls being told the drug was not addictive, as per Wall Street Journal. After a little over three weeks on it, he stopped taking it and says he was hit with severe and long-lasting withdrawal symptoms. These now include tremors, intense burning sensations across his body, muscle spasms, sleeplessness, and drastic weight loss. Several doctors later told him gabapentin was the likely cause. Avery says if he had known the drug required a slow taper, he would have refused it altogether.
Today, most gabapentin prescriptions are written for conditions it was never formally approved to treat by the US Food and Drug Administration. Doctors commonly prescribe it for long-term pain, anxiety, migraines, sleep problems, menopausal hot flashes, and more. While prescribing drugs off-label is legal and widespread, it also means the FDA has not formally evaluated the drug’s safety or benefits for many of these uses. Among people on Medicare, more than 90 percent of gabapentin prescriptions linked to doctor visits were for off-label reasons.
An expanding body of research suggests gabapentin may not be as harmless or as helpful as once believed. Studies have associated it with a higher risk of dementia, suicidal thoughts or behaviour, dangerous breathing problems in people with lung disease, swelling, and problems with thinking and memory. One recent study found that giving gabapentin to patients after surgery did not lower complications or shorten hospital stays. Instead, more patients reported ongoing pain months later.
Although medical guidance has long described gabapentin as non-habit-forming, many patients report serious symptoms when they try to reduce or stop the drug. These experiences point to physical dependence, even when gabapentin is taken exactly as prescribed.
Gabapentin is frequently taken alongside opioids, either by design or because prescriptions overlap. The US Centers for Disease Control and Prevention has warned that this combination can be fatal. Federal and state records show that at least 5,000 deaths each year over the past five years have involved gabapentin overdoses.
One of those deaths was Nancy Hammer, a 77-year-old woman from South Carolina. She was prescribed gabapentin along with an opioid and other drugs that slow the nervous system. A later toxicology report found that the mix suppressed her breathing until it stopped. Her family says they were never clearly told how risky the combination could be.
Gabapentin prescriptions have more than doubled in the past 15 years. This rise coincided with doctors pulling back from opioids and benzodiazepines as regulations tightened and scrutiny increased. For many clinicians, gabapentin became what one pain specialist described as a moral and regulatory “safe harbour” when they needed to treat pain quickly but had limited options.
Many doctors maintain that the drug does help certain patients and is often well tolerated. Others now argue that it has been prescribed too casually, used for too many complaints, and renewed too easily without enough follow-up.
As prescribing continues to rise, more researchers and doctors are questioning whether gabapentin represents another chapter in America’s long history of overprescribing. For some patients, a drug once promoted as a safer answer to pain has instead brought lasting harm.
Credits: Canva
A fast-spreading flu strain in the UK is leaving more people vomiting bile, according to health experts. “Superflu” is not a recognised medical term. It is a media phrase used to describe a particularly harsh flu season driven by a mutated Influenza A (H3N2) virus. In this case, the strain belongs to subclade K and has been linked to more severe symptoms and a higher number of infections.
Experts say this is partly because the virus has changed enough to slip past immunity built from earlier vaccinations or past illness, making outbreaks harder to control. Older adults and other high-risk groups tend to be affected most.
The label is used to highlight a genetically altered H3N2 strain that reduces how well current vaccines match the virus, even though the shots still help protect against serious illness. These changes can make flu seasons arrive sooner than usual and feel more intense than people expect.
Health officials say the H3N2 variant is proving tougher than expected and is also affecting people’s appetite. Experts suggest this version of the virus may be more aggressive due to genetic changes that have made it stronger and more harmful, increasing the risk of infection. Studies indicate it can trigger more intense body aches, sudden exhaustion, and flu symptoms that appear rapidly.
Many patients have described vomiting “yellow bile” as one of the standout symptoms of their flu infection. Virologists believe this may happen because the flu is suppressing appetite more than usual, leading people to vomit when their stomachs are empty.
People experiencing symptoms such as coughing, sore throat, or a runny nose have been advised to reduce contact with vulnerable groups. This includes older adults, pregnant women, and those with existing health conditions, as they face a higher risk of serious illness.
Hospital admissions for flu in England reached 3.8 per 100,000 people in early November, up from 2.4 the previous week at the end of October, as per Mirror. Dr Simon Clarke, an infectious disease specialist at the University of Reading, told the Daily Mail: “Vomiting bile happens when someone is throwing up on an empty stomach.”
Professor Paul Hunter, an infectious disease expert at the University of East Anglia, explained that vomiting yellow bile usually occurs after repeated vomiting on an empty stomach “due to inflammation of the stomach lining.” He added that while it is often referred to as ‘stomach flu’, this symptom can appear as part of influenza. He also pointed out that yellow bile vomiting is common with stomach bugs such as norovirus and rotavirus, which are currently circulating at lower-than-usual levels for this time of year.
Additional flu symptoms include muscle pain, fever, weakness, extreme tiredness, and a dry cough. These symptoms often start suddenly and usually mean staying in bed to recover. Professor Stephen Griffin, a virology expert at the University of Leeds, told the Daily Mail that people vomiting yellow bile should focus on staying hydrated. “It’s important to drink plenty of water, even if you’re being sick, because some fluid will still be absorbed,” he said.
Health leaders raised concerns in November 2025 after a sharp rise in flu cases earlier than expected. Experts think this may be linked to the H3N2 strain mutating seven times over the summer. Data from the UK Health Security Agency (UKHSA) showed that most identified flu viruses were H3N2. Flu-related hospital admissions in England were recorded at 3.8 per 100,000 people in early November, compared with 2.4 the week before. The agency noted that this level of admissions is normally seen in December. At the time, flu activity was more than three times higher than usual for that point in the year, with children and young people most affected.
Health officials have encouraged eligible people to get their Covid and flu vaccinations to lower the risk of severe illness and hospital stays. Booster doses are available for those over 65, care home residents, frontline health and social care staff, and pregnant women. While the vaccine formula was finalised in February to allow time for manufacturing, the mutated strain emerged in June, meaning it may not fully protect against this version of the virus. Experts stress, however, that vaccination remains important to reduce the chances of serious illness and infection.
Although flu-related hospital admissions fell slightly over the Christmas period, England’s chief medical officer has warned that the NHS remains under significant strain as colder weather adds pressure. New figures released last week showed 2,676 patients were in hospital with flu, down from 3,061 the previous week. This drop was partly credited to NHS teams vaccinating more than half a million additional people compared with last year. Demand on services remains heavy, with NHS 111 handling 414,562 calls over Christmas.
Professor Meghana Pandit, NHS National Medical Director, said: “It is encouraging to see fewer people being admitted to hospital with flu, but the NHS cannot afford to relax as temperatures fall and pressures are likely to increase in the New Year. If you are eligible and have not yet had your flu jab, please come forward. It is still worthwhile.”
Health Secretary Wes Streeting added: “We are still facing serious pressures. It is more important than ever for those who qualify to get their flu vaccination and for people to use A&E only when it is truly necessary.”
Credits: Canva
"A woman dies from cervical cancer every two minutes," says the United Nations (UN). The UN notes that cervical cancer is the fourth most common cancer in women. Stating a case studies, UN noted that Jeanette, who was diagnosed with cervical cancer, died a year after she was diagnosed. Every January, during the Cancer Awareness Month, the UN and the World Health Organization (WHO) underscore that the illness is both preventable and curable. The WHO tweeted that cervical cancer would be the first cancer ever in the world to be eliminated, if 90% of girls are vaccinated, 70% of women are screened, and 90% of women with cervical cancer receive treatment.
Cervical Cancer is a type of cancer that develops in layers of the cervix. It is caused by abnormal cell growth that can spread to another part of your body. There are two main types of cervical cancer. These are squamous cell carcinoma and adenocarcinoma.
Cervix is located in the pelvic cavity, about 3 to 6 inches inside the vaginal canal. It serves as the entrance to the uterus to the vagina. As per the World Health Organization (WHO), almost all cervical cancer are linked to human papillomaviruses (HPV) which are transmitted through sexual contact.
In 2022, around 660,000 women were diagnosed with cervical cancer globally and nearly 350,000 lost their lives to the disease, according to the World Health Organization. UNICEF warns that cervical cancer claims a woman’s life every two minutes.
Nearly all cases are linked to human papillomavirus, a very common sexually transmitted infection. While most people clear HPV naturally, persistent infection with high-risk strains can lead to cancer.
Cervical cancer has no symptoms in the early days and therefore, is hard to detect until it has spread.
Cervical cancer is largely preventable and, when detected early, highly treatable. The World Health Organization recommends HPV vaccination for girls aged 9 to 14, before they become sexually active, along with regular cervical screening from age 30, or 25 for women living with HIV.
Despite this, unequal access to vaccination, screening and treatment continues to drive higher rates of illness and deaths in regions such as sub-Saharan Africa, Central America and Southeast Asia.
© 2024 Bennett, Coleman & Company Limited